Vai al contenuto

Interazioni tra farmaci

Avapritinib + Netupitant-palonosetron

Gravità: Maggiore

Avapritinib and Netupitant-palonosetron: major interaction.

Ultimo aggiornamento

Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.

Il contenuto clinico di questa pagina è disponibile solo in inglese.

Sintesi

Netupitant is a moderate CYP3A4 inhibitor and can increase avapritinib concentrations. This raises the risk of avapritinib toxicity such as cognitive effects, intracranial hemorrhage and edema.

Cosa significa questa interazione in parole semplici

Avapritinib and Netupitant-palonosetron can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Avapritinib belongs to Oncology; Netupitant-palonosetron belongs to Gastrointestinal Tract.

Livello di evidenza: Moderate

Perché avviene

Inhibition of CYP3A4-mediated avapritinib metabolism by netupitant.

Cosa fare

Avoid the combination; use an antiemetic regimen without CYP3A4 inhibition. If unavoidable, follow avapritinib labeling for dose reduction with CYP3A inhibitors and monitor for adverse effects.

Cosa chiedere al farmacista

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Per gli utenti Pro+

Sblocca la pagina completa

Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Avapritinib e Netupitant-palonosetron, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.

Domande frequenti

Can I take Avapritinib with Netupitant-palonosetron?

MediHelp rates the interaction as major. Avapritinib and Netupitant-palonosetron can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Netupitant is a moderate CYP3A4 inhibitor and can increase avapritinib concentrations. This raises the risk of avapritinib toxicity such as cognitive effects, intracranial hemorrhage and edema.

How serious is the interaction between Avapritinib and Netupitant-palonosetron?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination; use an antiemetic regimen without CYP3A4 inhibition. If unavoidable, follow avapritinib labeling for dose reduction with CYP3A inhibitors and monitor for adverse effects.

What other medicines interact with Netupitant-palonosetron?

MediHelp also lists interactions of Netupitant-palonosetron with, for example, Apomorphine, Flibanserin, Apalutamide. The full list is on the Netupitant-palonosetron page.

Monografie complete, posologie e verifica delle interazioni nell'app MediHelp

Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.

Sfoglia dalla A alla Z · Interazioni tra farmaci

Scarica l'app Accedi